|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0013216,
umls-concept:C0023467,
umls-concept:C0030705,
umls-concept:C0040715,
umls-concept:C0332293,
umls-concept:C0439858,
umls-concept:C0599718,
umls-concept:C0599813,
umls-concept:C0599893,
umls-concept:C0681804,
umls-concept:C1522702,
umls-concept:C1556084,
umls-concept:C2349984
|
|
pubmed:issue |
28
|
|
pubmed:dateCreated |
2009-9-30
|
|
pubmed:abstractText |
Acute myeloid leukemia (AML) with translocation (t) (8;21) or inversion (inv) (16) is associated with a favorable prognosis when treated with intensive chemotherapy. In elderly patients, these AML types are rare, and intensive treatments are much less tolerated. We conducted a retrospective study to evaluate the characteristics and outcome of AML with t(8;21) or inv(16) in the elderly.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:Acute Leukemia French Association,
pubmed-author:BoisselNicolasN,
pubmed-author:CahnJean-YvesJY,
pubmed-author:CastaigneSylvieS,
pubmed-author:Core Binding Factor Acute Myeloid Leukemia (CBF AML) intergroup,
pubmed-author:DelaunayJacquesJ,
pubmed-author:DombretHervéH,
pubmed-author:EsterniBenjaminB,
pubmed-author:Groupe Ouest-Est des leucémies et autres maladies du sang (GOELAMS),
pubmed-author:GuilhotFrançoisF,
pubmed-author:HunaultMathildeM,
pubmed-author:PigneuxArnaudA,
pubmed-author:PrébetThomasT,
pubmed-author:QuesnelBrunoB,
pubmed-author:RecherChristianC,
pubmed-author:ReutenauerSarahS,
pubmed-author:TavernierEmmanuelleE,
pubmed-author:TerreChristineC,
pubmed-author:ThépotSylvainS,
pubmed-author:ThomasXavierX,
pubmed-author:UgoValérieV,
pubmed-author:VeyNorbertN,
pubmed-author:WitzFrancisF
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4747-53
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:19720919-Acute Disease,
pubmed-meshheading:19720919-Aged,
pubmed-meshheading:19720919-Aged, 80 and over,
pubmed-meshheading:19720919-Chromosome Inversion,
pubmed-meshheading:19720919-Chromosomes, Human, Pair 16,
pubmed-meshheading:19720919-Chromosomes, Human, Pair 21,
pubmed-meshheading:19720919-Chromosomes, Human, Pair 8,
pubmed-meshheading:19720919-Core Binding Factors,
pubmed-meshheading:19720919-Female,
pubmed-meshheading:19720919-Humans,
pubmed-meshheading:19720919-Leukemia, Myeloid,
pubmed-meshheading:19720919-Male,
pubmed-meshheading:19720919-Middle Aged,
pubmed-meshheading:19720919-Prognosis,
pubmed-meshheading:19720919-Retrospective Studies,
pubmed-meshheading:19720919-Survival Analysis,
pubmed-meshheading:19720919-Translocation, Genetic,
pubmed-meshheading:19720919-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
|
|
pubmed:affiliation |
Institut Paoli-Calmettes, 13009 Marseille, France.
|
|
pubmed:publicationType |
Journal Article
|
